Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MBL Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia
NCT00138736Phase 2Completed
- Sponsor
- Prothya Biosolutions
- Start
- Apr 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of mannan-binding lectin in Mannose-binding lectin deficiency, sponsored by Prothya Biosolutions. Started Apr 2004; status: completed.
02
Drugs
mannan-binding lectin
03
Conditions
Mannose-binding lectin deficiency
Beyond the preview
Go deeper on NCT00138736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00138736.